Islets Of Langerhans, often referred to as pancreatic islets, are micro-organs scattered throughout the pancreas and serve as key regulators of blood glucose levels. Comprising about 1-2% of the pancreas, these islets consist of several cell types, including alpha cells that produce glucagon, beta cells responsible for insulin secretion, delta cells that release somatostatin, and pancreatic polypeptide-secreting cells. Insulin, produced by beta cells, plays a central role in glucose homeostasis by promoting glucose uptake into cells and inhibiting liver glucose production. Glucagon, secreted by alpha cells, raises blood glucose levels by stimulating the breakdown of glycogen into glucose. Delta cells release somatostatin, regulating the release of insulin and glucagon. The coordinated actions of these hormones ensure precise control over blood glucose concentrations. Dysfunction of the islets of Langerhans is central to the development of diabetes mellitus, a metabolic disorder characterized by impaired insulin function or production. Understanding the intricate physiology of these islets is crucial for unraveling the mechanisms underlying diabetes and developing targeted therapeutic strategies. The Islets of Langerhans stand as a critical component in the orchestration of glucose metabolism, representing a key focus in diabetes research and the quest for innovative treatment approaches.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy